Organ Preservation Market
By Solution;
University of Wisconsin Solution, Custodial HTK, Perfadex, and Other SolutionsBy Technique;
Static Cold Storage, Hypothermic Machine Perfusion, and Normothermic Machine PerfusionBy Organ Type;
Kidney, Liver, Lung, Heart, and PancreasBy End User;
Organ Transplant Centers, Hospitals, and Specialty ClinicsBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Organ Preservation Market Overview
Organ Preservation Market (USD Million)
Organ Preservation Market was valued at USD 2,293.03 million in the year 2024. The size of this market is expected to increase to USD 3,568.02 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.5%.
Organ Preservation Market
*Market size in USD million
CAGR 6.5 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 6.5 % |
| Market Size (2024) | USD 2,293.03 Million |
| Market Size (2031) | USD 3,568.02 Million |
| Market Concentration | Medium |
| Report Pages | 396 |
Major Players
- XVIVO Perfusion AB
- Organ Recovery Systems, Inc
- Preservation Solutions, Inc
- TransMedics, Inc
- Waters Medical Systems LLC
- OrganOx Limited
- Bridge to Life Ltd
- OrganAssist BV
- Essential Pharmaceuticals LLC
- 21st Century Medicine Inc
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Organ Preservation Market
Fragmented - Highly competitive market without dominant players
The organ preservation market is seeing remarkable growth, driven by cutting-edge advancements in transplantation technology and a rise in the number of transplant surgeries conducted worldwide. Organ preservation plays a vital role in maintaining the viability and functionality of donor organs during transportation and pre-transplant phases, which significantly enhances patient outcomes and reduces the risk of organ rejection. Among the most widely used preservation methods, cold storage dominates with around 65% of usage, followed by hypothermic machine perfusion at 20%, and the emerging normothermic machine perfusion technique, which accounts for approximately 10–15%. These preservation techniques offer specific advantages tailored to various organ types and medical requirements.
Factors Driving Market Growth
The main driver of this market expansion is the growing incidence of end-stage organ failure, largely attributed to aging populations and a rise in chronic lifestyle-related conditions like diabetes, hypertension, and obesity. Approximately 10% of people worldwide are affected by chronic kidney disease, a leading cause of organ transplant demand. Currently, donor organ availability meets only 10–15% of the global demand for transplants, resulting in a critical shortage. This gap is amplifying the need for advanced organ preservation technologies, which can extend organ viability by 30–50% over traditional methods. These innovations are helping to increase the pool of organs that are viable for transplantation.
Government Initiatives and Investments
In addition to medical advancements, government policies and initiatives are playing a key role in accelerating market growth. Programs designed to raise awareness about organ donation and streamline transplantation systems have led to notable improvements. For example, organ donation registration rates have increased by 25–30% in regions that have implemented comprehensive awareness campaigns. Partnerships between healthcare providers, transplant centers, and regulatory bodies are enhancing organ procurement systems, allocation processes, and overall transplant success rates. Furthermore, increased investments from major industry players are driving research and development, with expected annual increases in R&D spending of 18–22%. These efforts are contributing to the development of next-generation preservation technologies that will improve access to transplantation services and address critical unmet needs in the global healthcare system.
Organ Preservation Market Recent Developments
-
In January 2023, transplant surgeons at MedStar Georgetown University Hospital in the Washington Metropolitan area, United States, successfully leveraged the newly FDA-approved OrganOx metra system to enhance liver transplantation procedures. This innovative technology mimics the physiological conditions of a human body by simulating the connection between a donated liver and its recipient. With the use of the OrganOx metra, the donated liver can now be preserved for up to 12 hours before transplantation, significantly improving the organ’s viability and offering greater flexibility for surgical planning and recipient matching.
-
In August 2022, Paragonix Technologies, Inc. achieved a major milestone by successfully preserving over 2,000 donor organs through the use of its Advanced Organ Preservation (AOPT) technology and an extensive statewide clinical support network. The company's innovative preservation systems, which feature first-of-their-kind methods, have delivered a significant advancement over traditional ice-and-cooler practices. By enhancing organ viability and safety during transport, Paragonix’s technologies are helping transplant hospitals improve patient outcomes and optimize transplantation success rates.
Organ Preservation Market Segment Analysis
In this report, the Organ Preservation Market has been segmented by Solution, Technique, Organ, End User, and Geography. Each segment is analyzed in terms of adoption trends, growth drivers, competitive positioning, and the broader clinical and commercial landscape over the forecast timeline (2021–2031).
Organ Preservation Market, Segmentation by Solution
The Organ Preservation Market has been segmented by Preservation Solution into UW, Custodial HTK, and Perfadex. These solutions form the foundation of modern organ transplantation procedures, and their demand reflects a mix of clinical efficacy, regional adoption, and institutional procurement strategies.
UW SolutionThe UW solution remains the global benchmark, accounting for the largest market share due to its ability to safeguard cellular metabolism and minimize ischemic injury. Adoption is particularly strong in kidney and liver transplants, where evidence supports superior outcomes. Market growth is supported by its entrenched clinical acceptance, ongoing innovations, and high levels of integration into hospital protocols worldwide.
Custodial HTK SolutionThe Custodial HTK solution holds a significant portion of the market, with demand driven by its low viscosity and ease of perfusion. This makes it highly effective in complex procedures such as heart and pancreas transplantation. Adoption is accelerating in European and Asian healthcare systems, reflecting the influence of regional clinical guidelines, evolving transplant policies, and favorable procurement costs compared to UW.
Perfadex SolutionThe Perfadex solution plays a critical role in lung transplantation, where it is recognized for reducing pulmonary edema and maintaining oxygenation capacity. Its adoption has grown steadily with the rising incidence of chronic lung diseases and the expansion of thoracic surgery programs in advanced medical centers. Market growth is also supported by expanding clinical trials and the increasing need for lung preservation solutions worldwide.
Organ Preservation Market, Segmentation by Technique
The Organ Preservation Market has been segmented by Technique into Static Cold Storage, Hypothermic Perfusion, and Normothermic Perfusion. Each technique represents different cost-benefit trade-offs and levels of technological advancement in preserving organ viability.
Static Cold StorageStatic Cold Storage (SCS) dominates the market, widely used due to its simplicity, cost-efficiency, and reliability. Holding the largest share, SCS remains indispensable for kidney and liver transplantation, especially in resource-constrained regions. Growth is reinforced by its integration into high-volume transplant centers and the consistent alignment of clinical outcomes with established global guidelines.
Hypothermic PerfusionHypothermic Perfusion is gaining momentum, supported by its ability to circulate specialized preservation solutions at low temperatures, improving graft survival and extending ischemia times. Adoption is particularly noticeable in heart and lung transplants, where conventional static methods are less effective. Growth prospects are shaped by increasing R&D investments and rising demand in advanced transplant centers seeking improved long-term outcomes.
Normothermic PerfusionNormothermic Perfusion is an emerging technique, offering the ability to maintain organs at near-physiological temperatures and allow real-time viability assessment. Although its current market share is smaller, adoption is expanding in specialized research-driven hospitals. Long-term growth is expected to be driven by its potential to reduce organ discard rates and enhance post-transplant recovery, positioning it as a key innovation in the preservation landscape.
Organ Preservation Market, Segmentation by Organ
The Organ Preservation Market has been segmented by Organ into Kidneys, Liver, and Heart. Each organ type reflects different transplant volumes, preservation demands, and evolving therapeutic priorities across global markets.
KidneysThe kidney segment dominates, representing the largest share of transplant procedures worldwide due to the growing burden of end-stage renal disease. Market growth is driven by increasing global donor programs, advancements in storage technologies, and expanding dialysis-to-transplant transitions. Success in this segment is reinforced by clinical evidence demonstrating improved graft survival with modern preservation solutions.
LiverThe liver segment holds a significant share of the market, with demand linked to the rising prevalence of cirrhosis, alcohol-related disorders, and hepatitis. Growth opportunities are concentrated in regions investing in advanced transplant infrastructure and adopting cutting-edge preservation technologies. The segment’s trajectory is shaped by expanding organ donation awareness campaigns and government initiatives supporting transplantation programs.
HeartThe heart segment represents a smaller but critical portion of the market. Despite lower transplant volumes compared to kidney and liver, heart preservation solutions are vital for managing end-stage heart failure. Market expansion is fueled by technological innovations in perfusion systems, improved long-distance transport capabilities, and growing patient eligibility through early detection of cardiovascular conditions.
Organ Preservation Market, Segmentation by End User
The Organ Preservation Market has been segmented by End User into Transplant Centers, Hospitals, and Specialty Clinics. Each end-user category plays a distinct role in the adoption and utilization of preservation solutions.
Transplant CentersTransplant centers dominate the end-user landscape, reflecting approximately half of the global demand. Equipped with advanced infrastructure and multidisciplinary expertise, these centers are the primary drivers of innovation and adoption in preservation technologies. Their leadership role is strengthened by rising global transplant volumes and integration into international clinical networks.
HospitalsHospitals represent a significant share of the market, particularly in managing kidney and liver transplants. Growth is shaped by their integration with emergency care services, evolving clinical protocols, and increasing partnerships with transplant networks. This segment benefits from ongoing public-private healthcare collaborations aimed at improving accessibility to transplantation.
Specialty ClinicsSpecialty clinics contribute a smaller but growing portion of demand, focusing on pre- and post-transplant management and offering niche support for multi-organ procedures. Expansion is supported by the rise of private healthcare providers and targeted patient referral programs, especially in developing markets.
Organ Preservation Market, Segmentation by Geography
In this report, the Organ Preservation Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Regional trends reflect differences in healthcare infrastructure, regulatory policies, and transplant adoption rates.
Regions and Countries Analyzed in this Report
North America leads the global market with a strong share, supported by advanced healthcare systems, high transplant volumes, and extensive government initiatives promoting organ donation. The region benefits from the presence of leading industry players and continued investment in innovative preservation techniques.
EuropeEurope represents the second-largest market, characterized by well-structured transplant programs, high levels of clinical research, and a strong culture of organ donation awareness. Countries such as Germany, the UK, and France are at the forefront, driving adoption of advanced technologies through supportive regulatory frameworks.
Asia PacificThe Asia Pacific region shows strong growth potential, driven by rising incidences of chronic organ-related diseases and expanding government investments in healthcare infrastructure. Rapid growth in countries such as India, China, and Japan reflects improving transplant infrastructure and increasing international collaborations.
Middle East & AfricaMEA contributes a smaller share but is witnessing expansion due to growing medical tourism, government-backed donation campaigns, and improvements in healthcare accessibility. Gulf nations are emerging as regional hubs, leveraging investments in specialized transplant programs.
Latin AmericaLatin America reflects gradual growth, with adoption concentrated in countries such as Brazil and Mexico. Despite challenges such as healthcare disparities and uneven infrastructure, rising awareness campaigns and public investments are gradually strengthening the region’s role in the global organ preservation landscape.
Organ Preservation Market Force
This report provides an in depth analysis of various factors that impact the dynamics of Organ Preservation Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Growing global elderly population
- Critical shortage of donor organs
- Breakthroughs in preservation technologies
- Rise in organ transplant procedures
-
Surge in chronic disease cases - The organ preservation market is experiencing significant growth, largely due to the increasing prevalence of chronic diseases across the world. Conditions like cardiovascular diseases, diabetes, kidney failure, and liver diseases are on the rise, often attributed to factors such as unhealthy diets, sedentary lifestyles, and aging populations. These diseases frequently lead to organ failure, which creates a greater demand for organ transplants as a life-saving treatment. As the demand for organs outpaces the availability of suitable donors, advanced organ preservation technologies play a crucial role in maintaining organ viability during transportation and storage, improving the likelihood of successful transplants. This growing need for effective preservation solutions is spurring innovation and investment, which has led to the development of more efficient preservation techniques and devices that enhance organ quality and transplant outcomes.
Medical technology and research advancements have revolutionized organ preservation, facilitating the development of new techniques that extend preservation times and enhance organ viability. Notable innovations include machine perfusion systems hypothermic and normothermic perfusion systems that offer superior organ preservation by maintaining ideal conditions for organ function outside the body. These technologies not only increase the duration organs can be preserved but also allow for organ viability assessments prior to transplantation, thereby reducing the risks of graft failure and rejection.
The increased adoption of organ preservation technologies is also driven by the expansion of organ procurement and transplantation programs worldwide. Government initiatives, along with collaborations between healthcare organizations and research institutions, have helped address the growing demand for organs. These efforts are vital for ensuring that the right preservation methods are in place to improve transplant success rates and, ultimately, patient outcomes.With these advancements and a rising demand for organ preservation solutions, the market for organ preservation is expected to continue its rapid growth, helping meet the increasing need for organ transplants globally.
Restraints:
- Restricted organ preservation technologies available
- Complex regulatory approval hurdles
- Expensive organ preservation procedures
- Low public awareness of preservation
-
Ongoing ethical debates in transplantation - The rapid advancement of organ preservation technologies has opened new possibilities in organ transplantation, offering hope to millions of patients in need of life-saving transplants. However, this progress also brings forth significant ethical issues. One of the most pressing ethical dilemmas involves the allocation of preserved organs. Given that the demand for organs far outweighs the supply, questions about the fairness of distribution inevitably arise. Should organ allocation be based on medical urgency, the recipient's socioeconomic status, or other criteria? As the principles of justice, beneficence, and autonomy come into play, determining who should receive these limited resources becomes an increasingly complex issue.
Ethical considerations in organ preservation extend beyond the allocation process to the very methods used for organ storage and viability extension. As preservation technologies evolve to prolong organ life outside the body, they raise significant questions about the definition of death and the ethics of intervening in the natural dying process. Prolonged preservation of organs calls into question the boundaries between life and death, especially when these advancements challenge traditional views on the timing of organ donation.
Ensuring that informed consent is obtained from organ donors becomes crucial as preservation techniques continue to advance. The ethical concerns of respecting the autonomy of donors grow as the line between organ donation and the potential commodification of human body parts becomes increasingly blurred. With the expansion of the organ preservation market, addressing these ethical challenges will require ongoing conversations, transparency, and a strong commitment to ethical principles like beneficence, non-maleficence, and justice. These principles are vital to ensuring that patient outcomes are improved while upholding the dignity and rights of donors.
Opportunities:
- Emerging markets
- Development of novel preservation solutions
- Collaborations and partnerships
- Focus on personalized medicine
-
Growing medical tourism industry - The organ preservation market is witnessing substantial growth, driven primarily by advancements in medical technology and a rising global demand for organ transplantation procedures. Organ preservation solutions are essential in maintaining the viability of organs during storage and transportation, ensuring they remain suitable for transplantation. As incidents of organ failure increase, and with a growing aging population, the need for organ transplants continues to rise, further intensifying the demand for effective organ preservation methods.
The rapid expansion of the medical tourism industry is also playing a significant role in the growth of the organ preservation market. Patients from developed nations are increasingly traveling to emerging economies where affordable medical treatments, including organ transplant procedures, are available. This trend is particularly prominent in countries with lower healthcare costs but high-quality medical infrastructure and skilled healthcare professionals. As a result, the demand for advanced organ preservation solutions is anticipated to increase in regions popular for medical tourism, spurring further market growth and technological innovation.
The organ preservation market is expanding due to the synergy between technological progress, the rising need for organ transplants, and the growth of the medical tourism industry. As these factors converge, the market for organ preservation technologies is expected to see continued growth, providing innovative solutions to meet the increasing demand for organ transplants worldwide.
Organ Preservation Market Competitive Landscape Analysis
Organ Preservation Market is characterized by strong competition among established players who emphasize strategies such as collaboration, partnerships, and merger activities to enhance their market presence. Companies are focusing on innovation and advanced product development, with nearly 65% of key participants investing in technological improvements to ensure long-term growth in this critical sector.
Market Structure and Concentration
The market demonstrates moderate concentration, where nearly 55% of share is captured by a few major players. This concentration is influenced by extensive R&D investments and technological advancements in preservation techniques. Smaller firms often enter through partnerships or niche strategies, creating a balance between established dominance and innovative entrants driving expansion.
Brand and Channel Strategies
Leading companies in the organ preservation field rely on strong brand visibility and diversified distribution strategies. More than 60% of manufacturers are enhancing online and direct hospital networks to strengthen supply chains. Consistent collaboration with medical institutions and partnerships with procurement organizations are critical in driving competitive advantage and fostering sustained growth.
Innovation Drivers and Technological Advancements
With nearly 70% of industry leaders investing in R&D, technological advancements remain central to competitive edge. Developments in machine perfusion and advanced preservation solutions are reshaping the market. Companies are adopting strategies centered on product innovation and process automation, ensuring significant growth prospects while reinforcing their positions through collaboration in medical research.
Regional Momentum and Expansion
Regional leaders account for around 58% of overall market activity, with strong momentum seen in emerging healthcare hubs. Companies are expanding through targeted partnerships and joint strategies to capture demand. Focused collaboration with regional health systems has become critical, enhancing growth potential and supporting long-term expansion in underserved regions.
Future Outlook
The future of the organ preservation industry is shaped by increasing emphasis on innovation, with nearly 62% of companies planning stronger R&D integration. Continuous technological advancements, combined with strategic partnerships, will sustain competitive momentum. The market will witness consistent growth as leading players drive expansion through collaborative models and adaptive preservation strategies.
Key players in Organ Preservation Market include::
- XVIVO Perfusion AB
- TransMedics, Inc.
- Paragonix Technologies, Inc.
- Dr. Franz Köhler Chemie GmbH
- OrganOx Limited
- Bridge to Life Ltd.
- Preservation Solutions, Inc.
- Global Transplant Solutions
- Organ Recovery Systems, Inc.
- 21st Century Medicine
- BioLife Solutions, Inc.
- Waters Medical Systems LLC
- CryoLife, Inc.
- Transplant Biomedicals
- Shanghai Genext Medical Technology Co., Ltd.
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Follow this format in all the markets
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Solution
- Market Snapshot, By Technique
- Market Snapshot, By Organ
- Market Snapshot, By End User
- Market Snapshot, By Region
- Organ Preservation Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Growing elderly population
- Critical shortage of donor organs
- Breakthroughs in preservation technologies
- Rise in organ transplant procedures
- Surge in chronic disease cases
- Restraints
- Restricted organ preservation technologies available
- Complex regulatory approval hurdles
- Expensive organ preservation procedures
- Low public awareness of preservation
- Ongoing ethical debates in transplantation
- Opportunities
- Emerging markets
- Development of novel preservation solutions
- Collaborations and partnerships
- Focus on personalized medicine
- Growing medical tourism industry
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Organ Preservation Market, By Solution, 2021 - 2031 (USD Million)
- University of Wisconsin Solution
- Custodial HTK
- Perfadex
- Other Solutions
- Organ Preservation Market, By Technique, 2021 - 2031 (USD Million)
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Organ Preservation Market, By Organ Type, 2021 - 2031 (USD Million)
- Kidney
- Liver
- Lung
- Heart
- Pancreas
- Organ Preservation Market, By End User, 2021 - 2031 (USD Million)
- Organ Transplant Centers
- Hospitals
- Specialty Clinics
- Organ Preservation Market, By Solution, 2021 - 2031 (USD Million)
- Organ Preservation Market Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Competitive Landscape
- Company Profiles
- XVIVO Perfusion AB
- TransMedics, Inc.
- Paragonix Technologies, Inc.
- Dr. Franz Köhler Chemie GmbH
- OrganOx Limited
- Bridge to Life Ltd.
- Preservation Solutions, Inc.
- Global Transplant Solutions
- Organ Recovery Systems, Inc.
- 21st Century Medicine
- BioLife Solutions, Inc.
- Waters Medical Systems LLC
- CryoLife, Inc.
- Transplant Biomedicals
- Shanghai Genext Medical Technology Co., Ltd.
- Company Profiles
- Analyst Views
- Future Outlook of the Market

